Bioinformatics | Cardiology | Endocrinology Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence. June 9, 2021
Cardiology | Endocrinology Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes. January 30, 2020